MedPath

HEMOLENS DIAGNOSTICS SP Z O O

🇵🇱Poland
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities.

Completed
Conditions
Coronary Artery Disease
Stable Ischemic Heart Disease
Interventions
Procedure: CCTA (Coronary Computed Tomography Angiography)
Procedure: ICA (Invasive Coronary Angiography)
Procedure: FFR (Fractional Flow Reserve)
Device: CNBP measurement
Device: Cardiolens FFR-CT Pro
First Posted Date
2021-03-02
Last Posted Date
2024-05-16
Lead Sponsor
Hemolens Diagnostics Sp. z o.o.
Target Recruit Count
450
Registration Number
NCT04777513
Locations
🇵🇱

American Heart of Poland, Centrum Kardiologii i Kardiochirurgii w Bielsku-Białej, Bielsko-Biala, Poland

🇵🇱

Oddział Kliniczny Kardiologii oraz Interwencji Sercowo-Naczyniowych Szpital Uniwersytecki w Krakowie, Cracovia, Poland

🇵🇱

The Cardinal Stefan Wyszyński National Institute of Cardiology, Warsaw, Poland

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath